Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95.9K Sell
5,170
-1,919
-27% -$38.2K 0.04% 431
2026
Q1
$133K Hold
7,089
0.04% 353
2025
Q4
$111K Buy
7,089
+1,546
+28% +$22.9K 0.03% 423
2025
Q3
$73.4K Buy
5,543
+2,083
+60% +$26.9K 0.02% 500
2025
Q2
$43K Buy
+3,460
New +$43.6K 0.02% 508

Other funds holding NOV

Essential Partners's NOV Position: Q2 2026 in Review

Essential Partners reduced its NOV (NOV) stake by 27% in Q2 2026, selling an estimated $38.2K and leaving 5,170 shares worth $95.9K. The position accounts for 0.04% of the portfolio, ranked #431.

Essential Partners first reported a position in NOV in Q2 2025 and has held it in 5 quarters since. The position peaked at $133K in Q1 2026. 487 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • Essential Partners held 5,170 shares of NOV worth $95.9K as of Q2 2026.
  • Essential Partners sold 1,919 NOV shares in Q2 2026, an estimated $38.2K.
  • NOV made up 0.04% of Essential Partners's portfolio in Q2 2026, its #431 holding.
  • Essential Partners first reported a position in NOV in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's NOV position peaked at $133K in Q1 2026.
  • 487 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.